Mohammad Azab

Insider Reports History

Entity
Individual
Location
C/O Supergen, Inc., 4140 Dublin Blvd., Suite 200, Dublin, CA
Signature
James Nisco, Attorney-in-Fact for Mohammad Azab
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mohammad Azab:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. Director Common Shares 74.2K $731K $9.85 Dec 19, 2023 Direct
LISATA THERAPEUTICS, INC. Director Common Stock 58.7K $175K $2.99 Jan 9, 2024 Direct
DURECT CORP Director Stock Option (right to buy) 5.5K Jun 21, 2023 Direct
Xenon Pharmaceuticals Inc. Director Stock Option (Right to Buy) 0 Dec 19, 2023 Direct

Insider Reports Filed by Mohammad Azab

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LSTA LISATA THERAPEUTICS, INC. Jan 9, 2024 1 $0 4 Jan 11, 2024 Director
XENE Xenon Pharmaceuticals Inc. Dec 19, 2023 4 $42.6K 4 Dec 20, 2023 Director
DRRX DURECT CORP Jun 21, 2023 1 $0 4 Jun 23, 2023 Director
XENE Xenon Pharmaceuticals Inc. Jun 2, 2023 1 $0 4 Jun 2, 2023 Director
LSTA LISATA THERAPEUTICS, INC. Jan 9, 2023 1 $0 4 Jan 11, 2023 Director
XENE Xenon Pharmaceuticals Inc. Dec 12, 2022 2 $8.27K 4 Dec 13, 2022 Director
LSTA LISATA THERAPEUTICS, INC. Sep 15, 2022 1 $120K 4 Sep 16, 2022 Director
LSTA LISATA THERAPEUTICS, INC. Sep 15, 2022 0 $0 3 Sep 16, 2022 Director
XENE Xenon Pharmaceuticals Inc. Jun 28, 2022 1 $0 4 Jun 29, 2022 Director
DRRX DURECT CORP Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
DRRX DURECT CORP May 24, 2022 5 $11.6K 4 May 25, 2022 Director
DRRX DURECT CORP May 16, 2022 4 $12.2K 4 May 18, 2022 Director
XENE Xenon Pharmaceuticals Inc. Dec 15, 2021 2 $11.3K 4 Dec 17, 2021 Director
DRRX DURECT CORP Jun 15, 2021 1 $0 4 Jun 16, 2021 Director
XENE Xenon Pharmaceuticals Inc. Jun 3, 2021 1 $0 4 Jun 3, 2021 Director